EULAR/PRINTO/PRES(安卡拉2008)IgA血管炎分类标准在成人中的表现
研究将EULAR/PRES认可的安卡拉2008 IgA血管炎分类标准应用于国际观察队列的178例IgA血管炎患者和1705例其他小血管及中血管血管炎对照,并测试修订版;修订标准敏感性76.4%(95%CI 69.8%至82.2%)、特异性94.5%(95%CI 93.4%至95.1%),在土耳其多中心血管炎注册的独立验证队列中敏感性97.8%(95%CI 94.0%至99.0%)、特异性85.0%(95%CI 78.0%至90.0%)。结论认为修订标准在成人IgA血管炎中表现良好,适合临床研究使用。
要点
- 安卡拉2008标准要求皮肤受累加四项之一:腹痛、活检示IgA沉积、关节炎或关节痛、肾脏受累。
- 将抗中性粒细胞胞质抗体阳性或血冷球蛋白阳性作为排除标准后,标准特异性提高。
- 修订标准在验证队列中敏感性97.8%、特异性85.0%。
核心结论
- 修订版EULAR/PRES认可的安卡拉2008 IgA血管炎分类标准在成人IgA血管炎中表现良好,适合用于临床研究。
研究设计与样本
- 国际观察性队列,纳入178例IgA血管炎患者和1705例其他小血管及中血管血管炎对照,评估安卡拉2008标准表现并测试可能修订。
- 修订标准随后在土耳其多中心血管炎注册的独立验证队列中评估。
主要发现
- 安卡拉2008标准要求皮肤受累加以下四项之一:腹痛、活检示IgA沉积、关节炎或关节痛、肾脏受累(任何血尿和/或蛋白尿)。
- 将抗中性粒细胞胞质抗体阳性或血冷球蛋白阳性作为排除标准后,标准特异性提高。
- 修订标准敏感性76.4%(95%CI 69.8%至82.2%),特异性94.5%(95%CI 93.4%至95.1%)。
- 验证队列中修订标准敏感性97.8%(95%CI 94.0%至99.0%),特异性85.0%(95%CI 78.0%至90.0%)。
关键数值与推荐
- 安卡拉2008分类标准:皮肤受累加腹痛、活检示IgA沉积、关节炎或关节痛、肾脏受累(任何血尿和/或蛋白尿)四项之一。
- 修订标准将抗中性粒细胞胞质抗体阳性或血冷球蛋白阳性列为排除标准。
临床怎么用
- 原文结论认为修订版EULAR/PRES认可的安卡拉2008 IgA血管炎分类标准适合用于临床研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the performance in adults of the European Alliance of Associations for Rheumatology (EULAR)/Pediatric Rheumatology European Society (PReS)-endorsed Ankara 2008 classification criteria for IgA vasculitis (IgAV). METHODS: The EULAR/PReS/Ankara 2008 classification criteria for IgAV were applied to patients enrolled in an international observational cohort which included patients with IgAV and comparators with other forms of small-vessel and medium-vessel vasculitis. After the initial assessment of the performance of the criteria, possible revisions to increase the performance were tested. The revised criteria were then assessed in an independent validation cohort within a multicentre Turkish vasculitis registry. RESULTS: The dataset consisted of 178 IgAV cases and 1705 comparators. The Ankara 2008 criteria require skin involvement plus one of the following four criteria: abdominal pain, a biopsy showing IgA deposition, arthritis or arthralgia, or renal involvement (any haematuria and/or proteinuria). The specificity of the criteria improved when a positive test for anti-neutrophil cytoplasmic autoantibody or blood cryoglobulins was considered an exclusion criterion. The revised criteria had a sensitivity of 76.4% (95% CI 69.8% to 82.2%) and a specificity of 94.5% (95.0% CI 93.4% to 95.1%). In the validation set, the sensitivity and specificity of the revised criteria were 97.8% (95% CI 94.0% to 99.0%) and 85.0% (95.0% CI 78.0% to 90.0%), respectively. CONCLUSION: The revised EULAR/PReS-endorsed Ankara 2008 IgAV classification criteria perform well in adults with IgAV and are appropriate for use in clinical research.
引用
- Bayindir Y, Grayson PC, Gribbons KB, et al. Performance in adults of the EULAR/PRINTO/PRES (Ankara 2008) classification criteria for IgA vasculitis. RMD Open. 2025. PMID: 40695543. doi:10.1136/rmdopen-2025-005728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。